Magnitude and reasons for pre-diagnosis attrition among presumptive multi-drug resistant tuberculosis patients in Bago Region, Myanmar

A mixed methods study

From:
Department for International Development
Published
10 May 2019
Country:
Burma
Document Type:
Journal Article
Theme:
Health
Authors:
Oo, T, Kyaw, K.W.Y., Soe, K.T., Saw, S, Satyanarayana, S and Aung, S.T.

Abstract

In Myanmar, Rifampicin resistant tuberculosis (RR-TB, a proxy for Multi-drug resistant TB) case detection is very low. This study objectives were to assess the proportion of eligible TB patients who had not undergone RR-TB testing (Xpert-MTB/Rif tests) in Bago Region, Myanmar and to understand the reasons and solutions for non-testing.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Oo T, Kyaw KWY, Soe KT, Saw S, Satyanarayana S, Aung ST. Magnitude and reasons for pre-diagnosis attrition among presumptive multi-drug resistant tuberculosis patients in Bago Region, Myanmar: A mixed methods study. Scientific Reports. 2019;9(1):7189.

Magnitude and reasons for pre-diagnosis attrition among presumptive multi-drug resistant tuberculosis patients in Bago Region, Myanmar: A mixed methods study

Updates to this page

Published 10 May 2019
Contents